Avoiding complacency when treating uncontrolled seizures: why and how?

References

• Sirven JI. Evaluation and management of drug-resistant epilepsy.. In: Garcia P, Dashe JF, editors. UpToDate. Alphen aan den Rijn. The Netherlands: Wolters Kluwer; 2017. Available from: https://www.uptodate.com/contents/evaluation-and-management-of-drug-resistant-epilepsy
   Google Scholar
• McCagh J, Fisk JE, Baker GA. Epilepsy, psychosocial and cognitive functioning. Epilepsy Res. 2009;86(1):1–14.
   PubMed Web of Science ®Google Scholar
• Spatt J, Bauer G, Baumgartner C, et al. Predictors for negative attitudes toward subjects with epilepsy: a representative survey in the general public in Austria. Epilepsia. 2005;46(5):736–742.
   PubMed Web of Science ®Google Scholar
• Trinka E, Bauer G, Oberaigner W, et al. Cause-specific mortality among patients with epilepsy: results from a 30-year cohort study. Epilepsia. 2013;54(3):495–501.
   PubMed Web of Science ®Google Scholar
• Gaitatzis A, Sisodiya SM, Sander JW. The somatic comorbidity of epilepsy: a weighty but often unrecognized burden. Epilepsia. 2012;53(8):1282–1293.
   PubMed Web of Science ®Google Scholar
• Laxer KD, Trinka E, Hirsch LJ, et al. The consequences of refractory epilepsy and its treatment. Epilepsy Behav. 2014;37:59–70.
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Sills GJ. Combining antiepileptic drugs–rational polytherapy? Seizure. 2011;20(5):369–375.
   PubMed Web of Science ®Google Scholar
• Margolis JM, Chu BC, Wang ZJ, et al. Effectiveness of antiepileptic drug combination therapy for partial-onset seizures based on mechanisms of action. JAMA Neurol. 2014;71(8):985–993.
   PubMed Web of Science ®Google Scholar
• Costa J, Fareleira F, Ascencao R, et al. Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis. Epilepsia. 2011;52(7):1280–1291.
   PubMed Web of Science ®Google Scholar
• World Health Organization, International league against epilepsy, international Bureau for Epilepsy. Atlas: Epilepsy Care in the World. Geneva, Switzerland: World Health Organization; 2005. Available from: http://www.who.int/mental_health/neurology/Epilepsy_atlas_r1.pdf.
   Google Scholar
• Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ilae commission on therapeutic strategies. Epilepsia. 2009;51(6):1069–1077.
   PubMed Web of Science ®Google Scholar
• Stephen LJ, Brodie MJ. Seizure freedom with more than one antiepileptic drug. Seizure. 2002;11(6):349–351.
   PubMed Web of Science ®Google Scholar
• Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314–319.
   PubMed Web of Science ®Google Scholar
• Mohanraj R, Brodie MJ. Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur J Neurol. 2006;13(3):277–282.
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Barry SJ, Bamagous GA, et al. Patterns of treatment response in newly diagnosed epilepsy. Neurology. 2012;78(20):1548–1554.
   PubMed Web of Science ®Google Scholar
• Chen Z, Brodie MJ, Liew D, et al. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 2018;75(3):279–286.
   PubMed Web of Science ®Google Scholar
• Sutula TP, Hagen J, Pitkanen A. Do epileptic seizures damage the brain? Curr Opin Neurol. 2003;16(2):189–195.
   PubMed Web of Science ®Google Scholar
• Whelan CD, Altmann A, Botia JA, et al. Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study. Brain. 2018;141(2):391–408.
   PubMedGoogle Scholar
• Worrell GA, Sencakova D, Jack CR, et al. Rapidly progressive hippocampal atrophy: evidence for a seizure-induced mechanism. Neurology. 2002;58(10):1553–1556.
   PubMed Web of Science ®Google Scholar
• Briellmann RS, Newton MR, Wellard RM, et al. Hippocampal sclerosis following brief generalized seizures in adulthood. Neurology. 2001;57(2):315–317.
   PubMed Web of Science ®Google Scholar
• Fuerst D, Shah J, Shah A, et al. Hippocampal sclerosis is a progressive disorder: a longitudinal volumetric MRI study. Ann Neurol. 2003;53(3):413–416.
   PubMed Web of Science ®Google Scholar
• Briellmann RS, Berkovic SF, Syngeniotis A, et al. Seizure-associated hippocampal volume loss: a longitudinal magnetic resonance study of temporal lobe epilepsy. Ann Neurol. 2002;51(5):641–644.
   PubMed Web of Science ®Google Scholar
• Thom M, Sisodiya SM, Beckett A, et al. Cytoarchitectural abnormalities in hippocampal sclerosis. J Neuropathol Exp Neurol. 2002;61(6):510–519.
   PubMed Web of Science ®Google Scholar
• Miller LA, Galioto R, Tremont G, et al. Cognitive impairment in older adults with epilepsy: characterization and risk factor analysis. Epilepsy Behav. 2016;56:113–117.
   PubMed Web of Science ®Google Scholar
• Vingerhoets G. Cognitive effects of seizures. Seizure. 2006;15(4):221–226.
   PubMed Web of Science ®Google Scholar
• Dalic L, Cook MJ. Managing drug-resistant epilepsy: challenges and solutions. Neuropsychiatr Dis Treat. 2016;12:2605–2616.
   PubMed Web of Science ®Google Scholar
• Keezer MR, Sisodiya SM, Sander JW. Comorbidities of epilepsy: current concepts and future perspectives. Lancet Neurol. 2016;15(1):106–115.
   PubMed Web of Science ®Google Scholar
• Villanueva V, Giron JM, Martin J, et al. Quality of life and economic impact of refractory epilepsy in Spain: the ESPERA study. Neurologia. 2013;28(4):195–204.
   PubMed Web of Science ®Google Scholar
• Micoulaud-Franchi JA, Bartolomei F, Duncan R, et al. Evaluating quality of life in epilepsy: the role of screening for adverse drug effects, depression, and anxiety. Epilepsy Behav. 2017;75:18–24.
   PubMed Web of Science ®Google Scholar
• Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Lancet Neurol. 2012;11(9):792–802.
   PubMed Web of Science ®Google Scholar
• Neligan A, Bell GS. The mortality of epilepsy. In: Sander JW, Walker MC, Smalls JE, editors. Epilepsy 2009: from benchside to bedside, a practical guide to epilepsy: lecture notes: twelfth epilepsy teaching weekend, 18–20 september 2009, St Anne’s College, Oxford. 12th ed. Oxford, UK: International League Against Epilepsy (UK Chapter) and The National Society for Epilepsy; 2009;37:1–2.
   Google Scholar
• Mbizvo GK, Bennett K, Simpson CR, et al. Epilepsy-related and other causes of mortality in people with epilepsy: a systematic review of systematic reviews. Epilepsy Res. 2019 Nov;157:106192. DOI: 10.1016/j.eplepsyres.2019.106192. Epub 2019 Aug 27. PMID: 31526975.
   Google Scholar
• Tomson T. Mortality in epilepsy. J Neurol. 2000;247(1):15–21.
   PubMed Web of Science ®Google Scholar
• Harden C, Tomson T, Gloss D, et al. Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsy Curr. 2017;17(3):180–187.
   PubMed Web of Science ®Google Scholar
• Kwan P, Schachter SC, Brodie MJ. Drug-resistant epilepsy. N Engl J Med. 2011;365(10):919–926.
   PubMed Web of Science ®Google Scholar
• Manford M. Recent advances in epilepsy. J Neurol. 2017;264(8):1811–1824.
   PubMed Web of Science ®Google Scholar
• French JA, Lawson JA, Yapici Z, et al. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016;388(10056):2153–2163.
   PubMed Web of Science ®Google Scholar
• Benbadis SR, Engel J. The next level of care in epilepsy. Neurol Clin Pract. 2019;9(4):284–285.
   PubMedGoogle Scholar
• American Academy of Neurology. AAN guideline summary for clinicians: treatments for refractory epilepsy. 2018. [cited Jun 28, 2018]. Available from: http://tools.aan.com/professionals/practice/pdfs/clinician_ep_treatment_e.pdf
   Google Scholar
• Benbadis S. The differential diagnosis of epilepsy: a critical review. Epilepsy Behav. 2009;15(1):15–21.
   PubMed Web of Science ®Google Scholar
• Amin U, Benbadis SR. The role of EEG in the erroneous diagnosis of epilepsy. J Clin Neurophysiol. 2019;36(4):294–297.
   PubMed Web of Science ®Google Scholar
• Benbadis SR, Geller E, Ryvlin P, et al. Putting it all together: options for intractable epilepsy: an updated algorithm on the use of epilepsy surgery and neurostimulation. Epilepsy Behav. 2018; 88s:33–38.
   PubMedGoogle Scholar
• Wiebe S, Blume WT, Girvin JP, et al. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311–318.
   PubMed Web of Science ®Google Scholar
• Engel J Jr., McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. Jama. 2012;307(9):922–930.
   PubMed Web of Science ®Google Scholar
• Englot DJ, Ouyang D, Garcia PA, et al. Epilepsy surgery trends in the United States, 1990–2008. Neurology. 2012;78(16):1200–1206.
   PubMed Web of Science ®Google Scholar
• Kossoff EHW. Ketogenic dietary therapies for the treatment of epilepsy. In: Nordli DR, Dashe JF, editors. UpToDate. Alphen aan den Rijn. The Netherlands: Wolters Kluwer;2019. [cited Sept 16]. Available from: https://www.uptodate.com/contents/ketogenic-dietary-therapies-for-the-treatment-of-epilepsy
   Google Scholar
• King-Stephens D, Mirro E, Weber PB, et al. Lateralization of mesial temporal lobe epilepsy with chronic ambulatory electrocorticography. Epilepsia. 2015;56(6):959–967.
   PubMed Web of Science ®Google Scholar
• Graham D, Tisdall MM, Gill D. Corpus callosotomy outcomes in pediatric patients: a systematic review. Epilepsia. 2016;57(7):1053–1068.
   PubMed Web of Science ®Google Scholar
• Lew SM. Hemispherectomy in the treatment of seizures: a review. Transl Pediatr. 2014;3(3):208–217.
   PubMedGoogle Scholar
• Schmeiser B, Zentner J, Steinhoff BJ, et al. Functional hemispherectomy is safe and effective in adult patients with epilepsy. Epilepsy Behav. 2017;77:19–25.
   PubMed Web of Science ®Google Scholar
• Varadkar S, Bien CG, Kruse CA, et al. Rasmussen’s encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol. 2014;13(2):195–205.
   PubMed Web of Science ®Google Scholar